Erastin,ferroptosis活化剂
Erastin, ferroptosis activator
Be the first to review this product! Submit a review
|
(5 Publications)
MW 547 Da, Purity >98%. Selective ferroptosis activator. Induces RAS-RAF-MEK-dependent non-apoptotic cell death via VDAC2 (IC50 = 0.1 μM).
查看别名
Amino acid transport system xc xCT antibody, Amino acid transport system xc-, B-36 vdac, C BAS/HAS, C HA RAS1, CCBR1, CTLO, Calcium channel blocker resistance protein CCBR1, Calcium channel blocker resistance protein CCBR1 antibody, Cysteine/glutamate transporter antibody, Cystine/glutamate transporter, FLJ23841, GTP and GDP binding peptide B, GTPase HRas, N-terminally processed, H RASIDX, H-Ras-1, HAMSV, HRAS, Ha Ras1 proto oncoprotein, Ha-Ras, Harvey rat sarcoma viral oncogene homolog, Harvey rat sarcoma viral oncoprotein, IF 1, IFG, IFI, IFN immune, IFN-gamma, IFNG_HUMAN, Immune interferon, Interferon gamma, K ras, N ras, OTTHUMP00000019878, OTTHUMP00000019879, OTTHUMP00000019880, OTTHUMP00000164578, Outer mitochondrial membrane protein porin 2, POR, Porin-2, RASH1, RASH_HUMAN, Ras family small GTP binding protein H Ras, SLC7A11, SYSTEM Xc(-) TRANSPORTER-RELATED PROTEIN, Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11, Solute carrier family 7 member 11, Solute carrier family 7, (cationic amino acid transporter, y+ system) member 11, Transformation gene oncogene HAMSV, Transforming protein p21, Type II Interferon, VDAC2_HUMAN, VH Ras, Vdac6, Voltage dependent anion channel 2, Voltage-dependent anion-selective channel protein 2, XCT_HUMAN, c has/bas p21 protein, c ras Ki 2 activated oncogene, c-H-ras, hVDAC2, p19 H RasIDX protein, p21ras, solute carrier family 7, v Ha ras Harvey rat sarcoma viral oncogene homolog, vHa RAS
- Chemical Structure
Unknown
Chemical Structure - Erastin, ferroptosis activator (AB209693)
2D chemical structure image of ab209693, Erastin, ferroptosis activator
产品详情
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The activities of these proteins contribute significantly to cellular processes and homeostasis. IFN-γ's main role involves modulation of the immune system by enhancing antigen presentation and promoting macrophage activation. HRAS is part of multiple protein complexes that dictate cellular proliferation and differentiation through its role in the MAPK and PI3K/AKT pathways. VDAC2 is essential for metabolite transport between the mitochondria and cytoplasm and its functions are tightly linked with mitochondrial apoptosis regulation. xCT's activity as part of a transporter complex helps maintain redox balance and prevent oxidative stress by importing cystine which can be converted to cysteine for glutathione biosynthesis an important antioxidant.
Pathways
These proteins contribute to distinct yet interconnected biological routes. IFN-γ is a critical player in the JAK-STAT signaling pathway which influences immune and inflammatory responses. HRAS’s involvement in the MAPK and PI3K/AKT pathways links it directly with cell growth and survival. VDAC2 plays an integral role in apoptosis pathways by interacting with apoptotic regulators like Bcl-2 family proteins thereby promoting or inhibiting cell death. xCT is a central part of the ferroptosis pathway due to its role in supplying cysteine for glutathione production and its activity is particularly relevant when discussing cell death linked to oxidative damage and ferroptosis markers.
文献 (5)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 12:739039 PubMed35185859
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 23:369-79 PubMed26794443
2016
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical pharmacology 105:14-22 PubMed26774450
2016
Applications
Unspecified application
Species
Unspecified reactive species
The Biochemical journal 473:769-77 PubMed26759376
2016
Applications
Unspecified application
Species
Unspecified reactive species
Journal of bioenergetics and biomembranes 40:213-7 PubMed18704666
2008
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com